Synthesis, anticancer evaluation, and molecular docking studies of benzoxazole linked combretastatin analogues

AbstractA novel series of benzoxazole linked combretastatin derivatives (11a–11n) have been synthesized and confirmed by1H NMR,13C NMR, and Mass spectral analysis. The synthesized compounds (11a–11n) were screened for anticancer activity against three human cancer cell lines, Breast (MCF-7), Lung (A549), and Melanoma (A375). Most of the compounds exhibit moderate to potent anticancer activity. Among the compounds,11g,11h,11l,11m, and11n showed more potent activity than the positive control Doxorubicin. In addition, compounds11g,11l,11m, and11n were carried out their molecular docking studies on EGFR receptor (PDB ID: 4hjo) and results indicated that11g and11l have strong binding interactions with the receptor. It was found that the binding energy calculations were in good agreement with the observed IC50 values.

http://link.springer.com/10.1007/s00044-020-02504-9

Source: Medicinal Chemistry Research - January 17, 2020 Category: Chemistry Source Type: research